Pfizer and torcetrapib


Category : Medical Rants

At the risk of redundancy, I will comment on the torcetrapib decision. For those who do not know what torcetrapib is – read this NY Times article – End of Drug Trial Is a Big Loss for Pfizer. Torcetrapib (trying saying that quickly) raised HDL levels. Many investigators think that raising HDL is the next frontier in secondary prevention of coronary artery disease.

Prior to getting FDA approval, drug companies must do clinical trials to demonstrate efficacy and safety. Unfortunately, torcetrapib failed the safety test.

The news came to Pfizer’s chief scientist, Dr. John L. LaMattina, as he was showering at 7 a.m. Saturday: the company’s most promising experimental drug, intended to treat heart disease, actually caused an increase in deaths and heart problems. Eighty-two people had died so far in a clinical trial, versus 51 people in the same trial who had not taken it.

Within hours, Pfizer, the world’s largest drug maker, told more than 100 trial investigators to stop giving patients the drug, called torcetrapib. Shortly after 9 p.m. Saturday, Pfizer announced that it had pulled the plug on the medicine entirely, turning the company’s nearly $1 billion investment in it into a total loss.

The abrupt decision to discontinue torcetrapib was a shocking disappointment for Pfizer and for people who suffer from heart disease. The drug, which has been in development since the early 1990s, raises so-called good cholesterol, and cardiologists had hoped it would reduce the buildup of plaques in blood vessels that can cause heart attacks. Just last Thursday, Pfizer’s chief executive, Jeffrey B. Kindler, said publicly that the drug could be among the most important new developments for heart disease in decades and that the company hoped to get Food and Drug Administration approval for it in 2007.

“I’m terribly disappointed,” said Dr. Steven E. Nissen, chairman of cardiovascular medicine at the Cleveland Clinic and lead investigator of an earlier torcetrapib clinical trial. “This drug, if it worked, would probably have been the largest-selling pharmaceutical in history.”

For people with heart disease, torcetrapib’s failure means that progress may be slowing after two decades of substantial advances against the disease. Medicines to lower blood pressure and bad cholesterol are already effective and widely used, yet heart disease remains the biggest cause of death in the United States, killing 911,000 people in 2003, according to the American Heart Association.

Heart disease patients do so much better in 2006 then 30 years ago. While a drug to increase HDL might help patients (obviously an unproven hypothesis), we actually have better ways available. Unfortunately, many patients would rather have a magic pill than to engage in the appropriate lifestyle changes.

The number one preventive measure remains smoking cessation. This totally trumps all drug therapy Weight reduction (for the obese) and exercise probably do as much as most drugs.

The problem with lifestyle changes is that they require patients to actively change their lives. Too many patients would rather search for that magic pill rather than confront the correctable lifestyle choices which they make daily.

The Food and Drug Administration said it endorsed Pfizer’s decision to end the trial and believed the company had acted properly. Torcetrapib’s failure is disappointing, but developing new drugs is risky and difficult, said Dr. Robert Meyer, director of the agency’s office of drug evaluation.

“Research is research,” Dr. Meyer said. “If you knew the answer, you wouldn’t be doing it.”

We should never forget that great theories do not always produce great results. We need randomized controlled trials to test theories. We should never skip that step.

Withdrawing this drug is a victory for patients, although we mourn those who died prematurely participating in this study. These studies are a victory for careful research and independent monitoring boards.

KevinMD has linked to a large number of blogs who have commented on this issue – Kevin MD on The torcetrapib disaster: Blogosphere response

free viagra
buy viagra online
generic viagra
how does viagra work
cheap viagra
buy viagra
buy viagra online inurl
viagra 6 free samples
viagra online
viagra for women
viagra side effects
female viagra
natural viagra
online viagra
cheapest viagra prices
herbal viagra
alternative to viagra
buy generic viagra
purchase viagra online
free viagra without prescription
viagra attorneys
free viagra samples before buying
buy generic viagra cheap
viagra uk
generic viagra online
try viagra for free
generic viagra from india
fda approves viagra
free viagra sample
what is better viagra or levitra
discount generic viagra online
viagra cialis levitra
viagra dosage
viagra cheap
viagra on line
best price for viagra
free sample pack of viagra
viagra generic
viagra without prescription
discount viagra
gay viagra
mail order viagra
viagra inurl
generic viagra online paypal
generic viagra overnight
generic viagra online pharmacy
generic viagra uk
buy cheap viagra online uk
suppliers of viagra
how long does viagra last
viagra sex
generic viagra soft tabs
generic viagra 100mg
buy viagra onli
generic viagra online without prescription
viagra energy drink
cheapest uk supplier viagra
viagra cialis
generic viagra safe
viagra professional
viagra sales
viagra free trial pack
viagra lawyers
over the counter viagra
best price for generic viagra
viagra jokes
buying viagra
viagra samples
viagra sample
generic cialis
cheapest cialis
buy cialis online
buying generic cialis
cialis for order
what are the side effects of cialis
buy generic cialis
what is the generic name for cialis
cheap cialis
cialis online
buy cialis
cialis side effects
how long does cialis last
cialis forum
cialis lawyer ohio
cialis attorneys
cialis attorney columbus
cialis injury lawyer ohio
cialis injury attorney ohio
cialis injury lawyer columbus
prices cialis
cialis lawyers
viagra cialis levitra
cialis lawyer columbus
online generic cialis
daily cialis
cialis injury attorney columbus
cialis attorney ohio
cialis cost
cialis professional
cialis super active
how does cialis work
what does cialis look like
cialis drug
viagra cialis
cialis to buy new zealand
cialis without prescription
free cialis
cialis soft tabs
discount cialis
cialis generic
generic cialis from india
cheap cialis sale online
cialis daily
cialis reviews
cialis generico
how can i take cialis
cheap cialis si
cialis vs viagra
generic levitra
levitra attorneys
what is better viagra or levitra
viagra cialis levitra
levitra side effects
buy levitra
levitra online
levitra dangers
how does levitra work
levitra lawyers
what is the difference between levitra and viagra
levitra versus viagra
which works better viagra or levitra
buy levitra and overnight shipping
levitra vs viagra
canidan pharmacies levitra
how long does levitra last
viagra cialis levitra
levitra acheter
comprare levitra
levitra ohne rezept
levitra 20mg
levitra senza ricetta
cheapest generic levitra
levitra compra
cheap levitra
levitra overnight
levitra generika
levitra kaufen

Comments (4)

I wish it was as simple as lifestyle changes. My total cholesterol level wasn’t ever very high and yet I still needed bypass surgery for 95% blockages at age 56. My main risk factor was a congenitally low HDL level, that never went up no matter what diet/exercises changes were made. This is a disappointment for many of us.

The time has come to realise that a legitimate hypothesis should have been laid to rest decades ago, but has been kept alive by the enormous revenues generated by statins.
People with low Total C can have heart attacks, people with high Total C often have none. That ought to have killed the whole cholestreol lowering fiasco stone dead.

The compliance rate for adherence to life-style changes / TLC [weight loss, dietary modification & exercise] is horrible. Wosre than ANY drug therapy. Dr Wm Castelli himself said in his recent Am J Cardiol interview with the editor,..”..the guideline writers obviously necer treat patients every day,.. if hey did they would see it [TLC] DOESN`T GET DONE !! They have to take the drugs !!’ In the same artcle he mentioned stains in a few paragraphs,.. no mention of fibrates,.. did mention fish oil,.. and spent a page & a half praising niacin. Hmmmmm. It is ALL in the fractions & ratios. Read the article,.. it is still cutting edge since our current myopia has kept us focused solely on LDL for over 20 years & not the global picture. See the video on Bradley Bale re GOOGLE to find it. 3800 patients followed for 10 years: ONE MI, no deaths. 89% statins, 83% ASA/Plavix, 74% ACE / ARB, 66% Rx Niacin, 53% TZD`s / Metformin.

Yes it IS in the cholesterol,..but it`s like a city,.. some good, some evil, some horribly dangerous [Lp(a)]. To quote Castelli [who sees similar results to Dr Bales`,.. “..They HAVE to taker the drugs !!..”

For the gentleman with severe [?] hypo-alphalipoproteinemia most common phenotype, yet NO fredrickson`s classification; 74% of all patients tested via ultracentrifuge/ VAp have low HDL2 & 30% that is the ONLY defect marked,.. low HDL2 [see Framingham data]. Niacin works slow,.. so do NOT be in a hurry. Start with carlson Labs 50 mg TID, titrate very slowuntil tachyphyaxis of the flush has occurred. Convert if Dr agrees to simpler Rx-ER-Niacin, after the TID “bolus” exceeeds 300 mg [900 mg/day]. ASA 325 & a fiber snack during titration. Castelli swears by Alka-Seltzer,.. I do as well. Your HDL2 will rise slowly, but it WILL rise:
113% at the 1st year on treatent with 1 gm daily. ~200% with 2 gms/daily. There IS NOTHING ELSE. Exercise, etOH, etc., are all ineffective on HDL2 and hat is the “game”. Again, ask Castelli, or sme one who actually knows,.. not merely the “holder of an opinion”. That is far too common. Most critiques of HDL treatment & niacin tx, are just that:
Observers, ‘opine-ers’ & NOT experienced clinicians. Anyone with 30% or more [Brad Bale, Castelli, Ziajka, Varveris, Taylor, etc.] of their dyslipidemic patients on 1-2 gms/daily niacin, have earned the right to profer an opinion.

Post a comment